| Primer | Genus | LP | RP | Tml | Tmr | Length | Score | Target | Senstive |
|---|---|---|---|---|---|---|---|---|---|
| Primer 2031 | Thermobifida | TCACCTGTCCCATCATGCG | TGGTCGGGAAGGGTGTACA | 59.78 | 60.15 | 277 | 57 |
100.00%
|
100.00%
|
| Primer 2032 | Thermobifida | ACTCAACCGTGCACTGCA | AGCGCTCATTGGATGCCA | 59.81 | 59.73 | 185 | 57 |
100.00%
|
100.00%
|
| Primer 2033 | Thermobifida | AGTGAACCAGATCGTGCCG | AATGTCTCCGGTGGCTTCG | 60.08 | 60.08 | 175 | 57 |
100.00%
|
100.00%
|
| Primer 2034 | Thermobifida | TTTCGACGTCGTTGAGCCC | GGCGAATTCTTCTGCTGCG | 60.66 | 59.94 | 229 | 57 |
100.00%
|
100.00%
|
| Primer 2035 | Thermobifida | TCGTAGCGGAGGACACTGA | GTATCAGCGTCTCCTGGTCG | 60.00 | 59.97 | 183 | 57 |
100.00%
|
100.00%
|
| Primer 2036 | Thermobifida | GTTCGTGTTGGTGCGCTAC | CAGGACGATCCAGCCGAAA | 59.80 | 59.78 | 157 | 57 |
100.00%
|
100.00%
|
| Primer 2037 | Thermobifida | TTCCGCACATGGGCAACT | CACGTCGATACCTTGCCCA | 59.88 | 59.78 | 260 | 57 |
100.00%
|
100.00%
|
| Primer 2038 | Thermobifida | ACGACTTCCATCCCGAAGC | TTCCCGATCAGTTCAGCCG | 59.78 | 59.78 | 238 | 57 |
100.00%
|
100.00%
|
| Primer 2039 | Thermobifida | AGGGCTCACCGACTCCAAA | TCGGCTTTGACGTGGGTAC | 60.84 | 60.01 | 258 | 57 |
100.00%
|
100.00%
|
| Primer 2040 | Thermobifida | AGCCAGTACAAGAGCAGCG | TGCGCTTCAAGCTCCTCA | 60.08 | 59.26 | 224 | 57 |
100.00%
|
100.00%
|